Literature DB >> 17003438

CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.

Qianli Meng1, Peizeng Yang, Bing Li, Hongyan Zhou, Xiangkun Huang, Lianxiang Zhu, Yalin Ren, Aize Kijlstra.   

Abstract

PURPOSE: To study the expression and functional characteristics of programmed death-1 (PD-1) and its ligands in the spleens of mice undergoing anterior chamber-associated immune deviation (ACAID).
METHODS: ACAID was induced in BALB/c mice by intracameral injection of ovalbumin (OVA). The expression of PD-1 and its ligands in the spleens of ACAID mice was determined by quantitative real-time PCR, Western blotting, and flow cytometry. In vitro proliferation assays, enzyme-linked immunosorbent assays, and adoptive transfer assays were used to investigate the functional characteristics of splenic CD4+PD-1+ T cells of ACAID mice.
RESULTS: Both mRNA and protein of PD-1, PD-L1, and PD-L2 were markedly upregulated in the spleens of ACAID mice compared with controls. CD4+PD-1+ T cells from ACAID mice produced large amounts of IL-10 and exhibited in vitro antigen-specific suppressive activity. CD4+PD-1+ T cells from ACAID mice were able to significantly inhibit the antigen-specific, delayed-type hypersensitivity response when adoptively transferred to naive mice.
CONCLUSIONS: CD4+PD-1+ T cells from ACAID mice, as regulatory cells, are involved in the induction of antigen-specific suppression in association with enhanced expression of IL-10. CD4+PD-1+ T cells in the murine spleen may represent a substantial population of regulatory T cells possibly responsible for the induction of ACAID after intracameral injection of antigen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003438     DOI: 10.1167/iovs.06-0201

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Effect of CD4(+)CD25(+) regulatory T cells in the development of anterior chamber-associated immune deviation.

Authors:  Shu-Xing Ji; Xiao-Lei Yin; Pei-Zeng Yang
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

2.  Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Authors:  Daniel Russell Richardson; Brian Ellis; Inderjit Mehmi; Monique Leys
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

3.  Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.

Authors:  Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

4.  Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.

Authors:  Celine S Lages; Ian Lewkowich; Alyssa Sproles; Marsha Wills-Karp; Claire Chougnet
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

5.  Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection.

Authors:  Nattawat Onlamoon; Kenneth Rogers; Ann E Mayne; Kovit Pattanapanyasat; Kazuyasu Mori; Francois Villinger; Aftab A Ansari
Journal:  Immunology       Date:  2008-02-05       Impact factor: 7.397

6.  CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.

Authors:  Xuefei Zhu; Peizeng Yang; Hongyan Zhou; Bing Li; Xiangkun Huang; Qianli Meng; Li Wang; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-31       Impact factor: 3.117

7.  Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han population.

Authors:  Qianli Meng; Haike Guo; Shengping Hou; Zhengxuan Jiang; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication.

Authors:  Oana Draghiciu; Hans W Nijman; Baukje Nynke Hoogeboom; Tjarko Meijerhof; Toos Daemen
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

9.  A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.

Authors:  Fang Lei; Junfeng Zhang; Jinsong Zhang; Hao He; Ying Du; Peizeng Yang
Journal:  Mol Vis       Date:  2008-02-11       Impact factor: 2.367

10.  Programmed Death 1 (PD-1) is involved in the development of proliferative diabetic retinopathy by mediating activation-induced apoptosis.

Authors:  Mengyuan Fang; Qianli Meng; Haike Guo; Liya Wang; Zhaoxia Zhao; Liang Zhang; Jian Kuang; Ying Cui; Liping Mai; Jiening Zhu
Journal:  Mol Vis       Date:  2015-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.